Appendix B Recommendation for enhanced surveillance of gonococcal infection
|
|
- Geoffrey Harrison
- 6 years ago
- Views:
Transcription
1 Appendix B Recommendation for enhanced surveillance of gonococcal infection
2 Enhanced gonococcal infection surveillance Recommendation for enhanced surveillance of gonorrhoea in the context of the increase in ciprofloxacin resistance of Neisseria gonorrhoeae During TCNMI meetings held on 8 and 9 April, 2005, the Groupe de travail sur le contrôle de l'infection gonococcique presented the following recommendation: Considering that the number of strains showing quinolone resistance has increased considerably since the last three months of 2003 and that the increase has affected men in particular; Number of ciprofloxacin-resistant strains and number of strains analysed at the LSPQ Women Men Total Resistant Analysed Resistant Analysed Resistant Analysed % No. ND gono % resistant ND * *First nine months of 2004 The last two columns are estimates of the minimal proportion of resistant strains, using the total number of reported gonococcal infections as the denominator. the data in the literature show similar findings affecting MSM in particular; the available data (2002 gonorrhoea investigations and a report on the free prescription medication program, 2003) indicate that quinolones continue to be used to treat gonorrhoea; information on quinolone use in 2005 to treat gonorrhoea is not well known; the available data (2002 gonorrhoea investigations) reveal an increase in the proportion of cases detected using NAAT only, and therefore these strains are not tested for resistance and their current situation is not well known; the Protocole d intervention ITS recommends conducting an epidemiological investigation after a case of gonococcal infection is reported and the working group endorses this recommendation; the feasibility and usefulness of compiling provincial data collected during investigations were demonstrated but are dependent on optimal regional participation, especially that of Montréal (65% of cases); Appendix B 1
3 enhanced surveillance of data collected during investigations conducted following reports of gonococcal infection between 2001 and 2003 has shown that risk factors are relatively stable; it is recommended to Reinstate provincial compilation of certain clinical and epidemiological data collected during epidemiological investigations, with the following objectives: o o Clearly identifying the treatment administered and, more specifically, better documenting quinolone use: in cases for which resistance is documented in cases in which risk of resistance is higher (MSM, infection acquired in an endemic country) in cases for which resistance was not measured in the context of screening vs. diagnosis Having an indicator for the application of new guidelines on the treatment of gonococcal infection that recommend avoidance of quinolones when the proportion of resistant strains is over 3% to 5% (as is the case in Québec). Specify the proportion of cases for which culture was not used for diagnostic testing (resistance impossible to detect). Caution is required because even in cases in which culture is used, susceptibility testing is not necessarily always performed. The LSPQ is concerned about this issue and is taking steps to correct the situation: o Compiling data from investigations can help achieve this objective (question 2.5). o The LSPQ is also collecting information from laboratories about techniques used. o Therefore, it would be useful and more effective to maintain and consolidate information sharing of data collected by public health and by the LSPQ, while respecting the legislative framework and the missions of each of these bodies. To reach this goal, the variables of interest are as follows: Sex, age and age group (section 1) Date of episode and region (section 1) Date of specimen collection (question 2.1) History of symptoms (to define the context: screening or diagnosis) (question 2.3) Site/type of positive samples (question 2.4) Technique used (question 2.5) Profile of resistance (question 2.6) Treatment prescribed (question 2.7) Partner s sex (question 3.7) Sexual relation with a person who usually lives outside Québec (question 3.14) 2 Appendix B
4 The TCNMI agreed to follow up on this recommendation, in keeping with the following modalities: Transmission to the Bureau de surveillance et de vigie (BSV)/MSSS of a de-identified copy of the investigation forms for all reported cases of gonococcal infection Transmission of forms starting 1 June, 2005 Data entry by the BSV and analysis by INSPQ in collaboration with MSSS Duration of the process anticipated to be a minimum of a year, that is, at least until 1 June, 2006 (reassessment of the pertinence of continuing with the process in April 2006: a year will probably not be enough to follow up on application of guidelines) Compilation and summary analysis of data performed on a monthly basis (INSPQ/BSV) Summary report distributed to the regions on a quarterly basis and more detailed annual report. Additional information will be passed on as required, following monthly analyses. 3 Appendix B
5 Appendix C Epidemiological surveillance of gonococcal infection
6 Epidemiological surveillance of gonococcal infection The epidemiological surveillance of infectious diseases provides direction to public health activities designed to prevent the greatest possible number of infections. This document describes how epidemiological surveillance of N. gonorrhoeae is conducted and managed in Québec. It explains how the notifiable disease system (MADO system) works, what is involved in an epidemiological investigation that is conducted once a case has been reported, including the attendant preventive interventions, the place given to enhanced surveillance, as well as the structure of the LSPQ's Programme de surveillance des souches de N. gonorrhoeae résistantes aux antibiotiques dans la province de Québec. 1. Notifiable disease surveillance Basic surveillance of certain diseases is performed by means of the notifiable disease system. This system stems from certain obligations provided for in the Public Health Act and the Minister s Regulation under the Act: The Minister shall, by regulation, draw up a list of intoxications, infections and diseases that must be reported to the appropriate public health director and, in certain cases provided for in the regulation, to the Minister or to both the public health director and the national public health director (sec. 79). The list may include only intoxications, infections or diseases that are medically recognized as capable of constituting a threat to the health of a population and as requiring vigilance on the part of public health authorities or an epidemiological investigation (sec. 80). The report must indicate the name and address of the person affected and contain any other personal or non-personal information prescribed by regulation of the Minister. The report must be transmitted in the manner, in the form and within the time prescribed in the regulation (sec. 81). Persons required to report (sec. 82): Any physician who diagnoses an STBI included in the list or who observes the presence of clinical manifestations characteristic of any of those STBIs in a living or deceased person, and any chief executive officer of a private or public laboratory or of a medical biology department, where a laboratory analysis conducted in the laboratory or department under his or her authority shows the presence of any STBI. In accordance with the Minister s Regulation under the Public Health Act, STBIs that must be reported are the following: Chancroid Granuloma inguinale Viral hepatitis Chlamydia trachomatis infection Gonococcal infection Lymphogranuloma venereum Appendix C 1
7 Syphilis HIV infection (reported by the physician only if the infected person has donated blood, organs or tissues, or received blood, blood products, organs or tissues) AIDS (reported by the physician only if the infected person has donated blood, organs or tissues, or received blood, blood products, organs or tissues) A written report must be transmitted to the public health director in the territory within 48 hours. The following information must be provided: Name of the infection or disease Name, sex, occupation, date of birth, address with postal code, telephone number and health insurance number of the person affected Date of onset of the disease The date on which the samples were taken and the name of the laboratory (or laboratories) that will analyse them, if needed In the case of viral hepatitis, syphilis, HIV infection and AIDS, all information pertaining to blood, organ or tissue donations made by the person affected and all information pertaining to blood, blood products, organs and tissues received by the person affected In the case of syphilis, information on the stage of the disease (primary, secondary, latent of less than or more than a year, congenital, tertiary or any other form) Information on the reporting physician (name, permit number, telephone numbers at which he or she can be reached) Signature and date of the report Reported cases of gonococcal infection must meet the definitions listed below. 1 Genitourinary gonococcal infection Confirmed case: Isolation of N. gonorrhoeae in a urogenital specimen or detection of N. gonorrhoeae by appropriate laboratory technique in a urethral or endocervical specimen or nucleic acid detection of N. gonorrhoeae in a urethral, endocervical or urinary specimen. Gonococcal eye infection Confirmed case: Isolation of N. gonorrhoeae from an ocular specimen. Other gonococcal infection Confirmed case: Isolation of N. gonorrhoeae from a clinical specimen other than ocular or urogenital. Data on reported cases are managed with a computerized system implemented in that links all 18 health regions to a common platform located at the LSPQ, where reported 2 Appendix C
8 notifiable disease cases are recorded. The aggregation of de-identified data allows description of the epidemiology of infections reported in Québec. The data are used to classify cases according to certain basic variables, such as sex, age and region of residence. 2. Epidemiological investigations and preventive interventions Interventions designed to prevent complications, reduce the duration of the infectious period and reduce the risk of transmission can be introduced after reception of an STI report. In accordance with the Public Health Act, the Protocole d intervention sur les infections transmissibles sexuellement à déclaration obligatoire 2 defines the recommended public health intervention to conduct after an STI has been reported. The protocol lists the infections that should, depending on the current epidemiological context, be the object of a high-priority public health intervention, that is, an epidemiological investigation that includes preventive interventions with people who have contracted an STI and with their partners (PIPSP). Gonococcal infections are among the infections identified as a priority. The intervention protocol describes the parameters of an epidemiological investigation, the contents of preventive advice to give an index case following a report, and the PIPSP. The epidemiological investigation to conduct after a report of a notifiable STI and the ensuing interventions meet surveillance, prevention and public health protection objectives. Surveillance and prevention objectives a) Validation Collect the required information to verify that case classification conforms to case definitions. b) Planning of preventive interventions Establish an overview of the epidemiological situation (age, sex, region and risk factors) that allows targets to be set for preventive interventions. Establish indicators to enable direct or indirect evaluation of the preventive intervention (e.g. screening programs, treatment guidelines). Public health protection objectives a) Reduce the rate of exposure to an STI. b) Reduce the effectiveness of STI transmission. c) Reduce the duration of infectiousness of an STI. As a complement to data collection for surveillance purposes, the following interventions can also be conducted in the context of an epidemiological investigation: Counsel the index case to prevent him or her from transmitting the infection and to prevent future exposures or reinfections: reduction in number of partners, use of barrier methods, safe sexual practices, advice concerning harm reduction related to addiction. Facilitate access to appropriate treatment. 3 Appendix C
9 Detect possibilities of treatment failure and notify the attending physician. Offer hepatitis A and B vaccination, in accordance with the recommendations of the MSSS s free vaccination program. Inform the index case about preventive interventions for partners and offer support that is in line with regional organization. Refer the individuals (index case and his or her partners) to services that meet their needs. Although the Act and its regulations establish obligations for physicians and public health departments, it can sometimes be difficult to complete an epidemiological investigation. Such difficulties can influence the quality of surveillance data obtained during such an investigation. 3. Health intervention to enhance surveillance of gonococcal infection in Québec Basic surveillance can be periodically enhanced when a situation requires it, as was the case when a significant increase in the number of reported cases of gonococcal infection was recorded (beginning in 1998), or when fluoroquinolone-resistant gonorrhoea started to spread in the province. Public health departments and the Direction générale de la santé publique du MSSS thought it worthwhile to collect more detailed or more specific information about certain elements. In 2001, agreement was reached with all public health departments to systematically conduct epidemiological investigations after a case of gonococcal infection has been reported and to use a common questionnaire to facilitate enhanced surveillance of the evolution of the situation. Data analysis results are presented in the Rapport d analyse Enquêtes épidémiologiques réalisées suite à une déclaration d infection gonococcique, 1 er mars décembre In April 2005, the TCNMI decided to implement a second intervention to enhance surveillance of gonococcal infection. This decision was made on the basis of a recommendation of the working group (see Appendix B). The Final report health intervention. Enhanced surveillance of gonococcal infection in Québec, 1 June 2005 to 31 May presents the analysis of data collected during this year of observation. 4. Program for the surveillance of antibiotic-resistant strains of N. gonorrhoeae in the province of Québec 5 The goal of the program for the surveillance of antibiotic-resistant strains of N. gonorrhoeae in the province of Québec, implemented by the LSPQ in 1998, is to collect data on the epidemiology of gonococcal infections, rates of resistance and the emergence of new types of resistance to the antibiotics used to treat gonococcal infections. Given the increase in fluoroquinolone resistance observed beginning in 2004 and as announced to microbiology laboratories in January 2005, the LSPQ decided, after consulting its partners, to focus surveillance on ciprofloxacin-resistant strains of N. gonorrhoeae and on the possible emergence of strains that are less susceptible to ceftriaxone. 4 Appendix C
10 Participating laboratories contribute in two distinct ways: 1. Monthly transmission of forms indicating the total number of patient strains of N. gonorrhoeae isolates observed in the laboratory as well as the number of cases for which gonorrhoea is detected in clinical specimens using gene amplification only (e.g. PCR). 2. Sending to the LSPQ all patient strains (one strain per patient within a period of seven days) with decreased susceptibility to a fluoroquinolone (e.g. ciprofloxacin) or cephalosporin (e.g. ceftriaxone, cefotaxime or cefixime). Other strains are also forwarded: strains isolated in children ( 14 years) or those ineffectively treated, those acquired outside Canada and those with unusual characteristics. In 2005, N. gonorrhoeae strains sent to the LSPQ were characterized according to susceptibility to ceftriaxone and ciprofloxacin, as determined using an agar dilution method in accordance with the procedures recommended by the Clinical and Laboratory Standards Institute. Strains showing resistance to ciprofloxacin are sent to the National Microbiology Laboratory in Winnipeg for further characterization (plasmid profile, auxotyping, serotyping or gene amplification), as part of the Canadian Surveillance Program. This program provides access to information such as the incidence of gonococcal infections, rate of ciprofloxacin-resistant strains, fluctuations and regional distribution of these strains, as well as possible emergence of resistance to cephalosporins. The data can be informative for public health authorities that must decide on the different treatment regimens to use for gonococcal infections. 5 Appendix C
11 Bibliography 1. MINISTÈRE DE LA SANTÉ ET DES SERVICES SOCIAUX. Surveillance des maladies à déclaration obligatoire au Québec : Définitions nosologiques Maladies d origine infectieuse, 6 th ed, Québec, ministère de la Santé et des Services sociaux, June MINISTÈRE DE LA SANTÉ ET DES SERVICES SOCIAUX. Les infections transmissibles sexuellement à déclaration obligatoire : Protocole d intervention, Québec, ministère de la Santé et des Services sociaux, March 2004, various pages. 3. Sylvie VENNE. Rapport d analyse Enquêtes épidémiologiques réalisées suite à une déclaration d infection gonococcique, 1 er mars décembre 2001, Québec, ministère de la Santé et des Services sociaux, September Pier Raymond ALLARD et al. Final report health intervention. Enhanced surveillance of gonococcal infection in Québec, 1 June 2005 to 31 May 2006, Québec, Institut national de santé publique du Québec and Bureau de surveillance et de vigie (maladies infectieuses) du ministère de la Santé et des Services sociaux, December LOUISE JETTÉ and Louise RINGUETTE. Surveillance des souches de Neisseria gonorrhoeae résistantes aux antibiotiques dans la province de Québec, Rapport 2005, Laboratoire de santé publique du Québec, Institut national de santé publique du Québec, April [On line] [ 6 Appendix C
The objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and
1 Antimicrobial resistant gonorrhea is an emerging public health threat that needs to be addressed. Neisseria gonorrhoeae is able to develop resistance to antimicrobials quickly. Effective antibiotic stewardship
More informationHPSC SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 2010
HPSC SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 21 Health Protection Surveillance Centre, www.hpsc.ie Version 1. May 212 Table of Contents Acknowledgements... 5 Key Points... 5 Introduction... 7 Methods...
More informationSexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2011
Sexually Transmitted Infection surveillance in Northern Ireland 2012 An analysis of data for the calendar year 2011 Contents Page Summary points. 3 Surveillance arrangements and sources of data.. 4 1:
More informationQuarterly Report on Sexually Transmitted Infections. Quarter (including annual summary)
Quarterly Report on Sexually Transmitted Infections Quarter 4 2000 (including annual summary) Report by The National Disease Surveillance Centre NDSC would like to thank all those who provided data for
More informationHPSC SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 2011
HPSC SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 2011 Health Protection Surveillance Centre, www.hpsc.ie Version 2.1 October, 2012 Table of Contents Acknowledgements... 3 Key Points... 3 Introduction...
More informationREPORT ON SEXUALLY TRANSMITTED INFECTIONS IN CANADA: 2012
REPORT ON SEXUALLY TRANSMITTED INFECTIONS IN CANADA: 2012 CENTRE FOR COMMUNICABLE DISEASES AND INFECTION CONTROL PUBLIC HEALTH AGENCY OF CANADA PROTECTING CANADIANS FROM ILLNESS TO PROMOTE AND PROTECT
More informationReport on sexually transmitted infections (STIs) in the Eastern Region: / Piaras O'Lorcain, Margaret Fitzgerald
Report on sexually transmitted infections (STIs) in the Eastern Region: 1994-3 / Piaras O'Lorcain, Margaret Fitzgerald Item type Authors Rights Report O'Lorcain, Piaras; Fitzgerald, Margaret ERHA Downloaded
More informationSexually Transmitted Infections In Manitoba
Sexually Transmitted Infections In Manitoba 2014 A focus on bacterial sexually transmitted infections Data reported to December 31, 2014 Epidemiology & Surveillance Public Health Branch Public Health and
More informationSurvey questionnaire on STI. surveillance, care and prevention. in European countries SAMPLE APPENDIX
European Surveillance of Sexually Transmitted Infections Survey questionnaire on STI surveillance, care and prevention in European countries APPENDIX Detailed questionnaire on clinician and laboratory
More informationQuarterly report on sexually transmitted infections - Quarter 1, 2001
Quarterly report on sexually transmitted infections - Quarter 1, 2001 Item type Authors Rights Report National Disease Surveillance Centre (NDSC) National Disease Surveillance Centre Downloaded 7-Jul-2018
More informationSTD UPDATE Patrick Loose, Chief HIV, STD & Hepatitis Branch February 15, 2018
Patrick Loose, Chief HIV, STD & Hepatitis Branch February 15, 2018 MISSION Improve health outcomes in communities disproportionately impacted by HIV and STDs Collect, study and publish data Diagnose and
More informationScottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018
Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018 Page 1 Contents 1 Introduction Page 3 2 Contact details Page 4 3 Opening hours Page 4 4 Services provided
More informationThe Communicable Disease Control Regulations
COMMUNICABLE DISEASE CONTROL 1 The Communicable Disease Control Regulations Repealed by Chapter P-37.1 Reg 11 (effective April 17, 2003). Formerly Chapter P-37.1 Reg 4 (effective January 1, 1997). NOTE:
More informationCOMMUNICABLE DISEASE REPORT
June 2011 Department of Health and Community Services Government of Newfoundland and Labrador COMMUNICABLE DISEASE REPORT Reporting Sexually Transmitted and Bloodborne Infections All laboratory-confirmed
More informationManitoba Health Statistical Update on HIV/AIDS
Manitoba Health Statistical Update on HIV/AIDS 1985-2002 Communicable Disease Control Unit Public Health MANITOBA HEALTH STATISTICAL UPDATE ON HIV/AIDS 1985 TO December 2002 HIV January 1, 1985 to December
More informationHealth Protection Surveillance Centre HPSC
HPSC TRENDS IN SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 1995 TO 2012 Table of Contents Acknowledgements...3 Key Points...3 Introduction...4 Methods...4 General Trends...5 Chlamydia trachomatis infection...6
More informationInstitut national de santé publique du Québec 1
Appendix A An opinion on the detection of gonococcal infection in Québec biomedical laboratories in response to the emergence of N. gonorrhoeae resistance to ciprofloxacin Institut national de santé publique
More informationGUIDELINES FOR THE MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS
WHO/HIV_AIDS/2001.01 WHO/RHR/01.10 Original: English Distr.: General GUIDELINES FOR THE MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS World Health Organization Copyright World Health Organization 2001.
More information6. Gonococcal antimicrobial susceptibility
6. Gonococcal antimicrobial susceptibility Key points Gonococcal AMR continues to increase worldwide and could lead to a pandemic of extensively drug-resistant (XDR) N. gonorrhoeae with serious public
More informationACKNOWLEDGEMENTS FOR FURTHER INFORMATION
ACKNOWLEDGEMENTS This report details the descriptive epidemiology of chlamydia and gonorrhea in the Winnipeg Health Region. Special gratitude is extended to the following individuals: Communicable Disease
More informationAnnual summary report on sexually transmitted infections 2003 / Niamh Murphy, Sarah Jackson, Mary Cronin
Annual summary report on sexually transmitted infections 2003 / Niamh Murphy, Sarah Jackson, Mary Cronin Item Type Report Authors Murphy, Niamh;Jackson, Sarah;Cronin, Mary Rights HPSC Download date 23/08/2018
More informationSexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2016
Sexually Transmitted Infection surveillance in Northern Ireland 2017 An analysis of data for the calendar year 2016 Contents Page Summary points. 3 Surveillance arrangements and sources of data.. 4 1:
More informationNotifiable Sexually Transmitted Infections 2009 Annual Report
Notifiable Sexually Transmitted Infections 29 Annual Report 21 Government of Alberta Alberta Health and Wellness, Surveillance and Assessment Send inquiries to: Health.Surveillance@gov.ab.ca Notifiable
More informationREPORT ON THE ENHANCED SURVEILLANCE OF ANTIMICROBIAL-RESISTANT GONORRHEA
i Report on the enhanced surveillance of antimicrobial-resistant gonorrhea REPORT ON THE ENHANCED SURVEILLANCE OF ANTIMICROBIAL-RESISTANT GONORRHEA RESULTS FROM THE 2014 PILOT i TO PROMOTE AND PROTECT
More informationSTI in British Columbia: Annual Surveillance Report
STI in British Columbia: Annual Surveillance Report 212 Contact Information BC Centre for Disease Control Clinical Prevention Services 655 West 12th Avenue Vancouver BC V5Z 4R4 Phone: 64-77-5621 Fax: 66-77-564
More informationTitle: What impact does missing Québec data have on national HIV surveillance data?
Track 1.2.4: Quantifying and Interpreting biases in epidemiologic and Title: What impact does missing Québec have on national HIV? Authors: Kristina Lalonde Tomas 1, Raphaël Bitera 2, Michel Alary 2, Micheline
More informationFigure 1. Serogroups of Neisseria meningitidis invasive infection cases in the province of Québec, Canada,
Context Figure 1. Serogroups of Neisseria meningitidis invasive infection cases in the province of Québec, Canada, 1997-2010. In Gilca R, Lefebvre B, Bourgault AM, Deceuninck G, Gilca V, Tsang SWR, et
More informationScottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Report for the period January - December 2011
Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Report for the period January - ember 211 Kirstine Eastick PhD FRCPath (Director) SBSTIRL, Microbiology Edinburgh
More informationCDC Laboratory Update
CDC Laboratory Update Chlamydia and Gonorrhea Laboratory Guidelines Overview of the APHL / CDC STD Steering Committee Laboratory Recommendations for the Detection of Chlamydia trachomatis, Neisseria gonorrhoeae
More informationGuidance on the use of molecular testing for Neisseria gonorrhoeae in Diagnostic Laboratories 2011
Guidance on the use of molecular testing for Neisseria gonorrhoeae in Diagnostic Laboratories 2011 Molecular testing for gonorrhoea working group (see Appendix) Prepared by Kirstine Eastick March 2012-1
More informationS403- Update on STIs for the Generalists
S403- Update on STIs for the Generalists Mobeen H. Rathore, MD Professor and Director University of Florida Center for HIV/AIDS Research Education and Service (UF CARES) Chief, Pediatric Infectious Diseases
More informationCOMMUNICABLE DISEASE REPORT
COMMUNICABLE DISEASE REPORT Quarterly Report Volume 29, Number 3 September 2012 Sexually Transmitted and Bloodborne Infections Reporting All laboratory confirmed sexually transmitted and bloodborne infections
More informationSTI in British Columbia: Annual Surveillance Report
STI in British Columbia: Annual Surveillance Report 211 Contact Information BC Centre for Disease Control Clinical Prevention Services 655 West 12th Avenue Vancouver BC V5Z 4R4 Phone: 64-77-5621 Fax: 66-77-564
More informationMoving Forward Sexually Transmitted Infections, including HIV, in Scotland 2005
Moving Forward Sexually Transmitted Infections, including HIV, in Scotland 25 NHS National Services Scotland /Crown Copyright 26 First published November 26 ISBN 1-873772-19-X Brief extracts from this
More informationSTI SURVEILLANCE. October December Quarterly Report. Prepared as part of the Ministry of Health contract for scientific services
STI SURVEILLANCE October December 2003 Quarterly Report Prepared as part of the Ministry of Health contract for scientific services by STI Surveillance Team March 2004 Client Report FW 0414 DISCLAIMER
More informationSTDs and Hepatitis C
STDs and Hepatitis C Catherine S. O Neal, MD Assistant Professor of Clinical Medicine, Infectious Diseases Louisiana State University Health Sciences Center March 3, 2018 Objectives Review patient risk
More informationSTI Treatment Guidelines. Teodora Wi. Training Course in Sexual and Reproductive Health Research
Teodora Wi Geneva, 28 August 2017 STI Treatment Guidelines Teodora Wi Training Course in Sexual and Reproductive Health Research 2017 Twitter @HRPresearch 1 STI treatment guidelines Neisseria gonorrhoeae
More informationLooking at NY: Our rate of chlamydia is higher than the US as a whole; we rank 13th among all states.
1 In this presentation, we will discuss: What are the most common STDs in NYS What are the most common STDs Can I get gonorrhea from oral sex How do you know if you/or your partner has an STD? Does getting
More informationSexually Transmitted Infection, including HIV, Health Protection Scotland Slide Set
Sexually Transmitted Infection, including HIV, 213 Health Protection Scotland Slide Set Enhanced surveillance systems are employed to give more detailed information on the epidemiology of infectious syphilis
More informationChanging Provincial Regulations: The Newborn Eye Prophylaxis Story
Changing Provincial Regulations: The Newborn Eye Prophylaxis Story Janet Walker, RN Director, Provincial Knowledge Transformation & Acute Care Healthy Mothers and Healthy Babies Conference March 12, 2016
More informationSTI control. Dr. Jane Morgan Hamilton Sexual Health Clinic
STI control Dr. Jane Morgan Hamilton Sexual Health Clinic Overview STI control in theory NZ s reality Where to from here? STI control framework R0=ßcD R0 = reproductive rate; the rate at which infection
More informationEDUCATION BULLETIN / INFLUENZA A (H1N1)
EDUCATION BULLETIN / INFLUENZA A (H1N1) TO: School boards, CEGEPs, universities and private teaching institutions DATE: November 17, 2009 SUBJECT: Second wave of the Influenza A (H1N1) pandemic in Québec
More informationOAML Guideline on the Investigation of Genital Tract Infections November, 2015
OAML Guideline on the Investigation of Genital Tract Infections November, 2015 1. Purpose The purpose of this guideline is to provide ordering clinicians with a clear and concise reference for the investigation
More informationTimby/Smith: Introductory Medical-Surgical Nursing, 9/e
Timby/Smith: Introductory Medical-Surgical Nursing, 9/e Chapter 62: Caring for Clients With Sexually Transmitted Diseases Slide 1 Epidemiology Introduction Study of the occurrence, distribution, and causes
More informationChlamydia Trachomatis and Neisseria Gonorrhoeae. Khalil G. Ghanem, MD Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationTrends in Reportable Sexually Transmitted Diseases in the United States, 2007
Trends in Reportable Sexually Transmitted Diseases in the United States, 2007 National Surveillance Data for Chlamydia, Gonorrhea, and Syphilis Sexually transmitted diseases (STDs) remain a major public
More informationNew Brunswick Report on Sexually Transmitted and Blood Borne Infections, 2016
New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 6 Table of Contents. Introduction.... Methodology... 3. Data Limitations.... Definitions used... 3 5. Overview of STBBI epidemiology
More information6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?
BACTERIAL STDs IN A POST- HIV WORLD Tracey Graney, PhD, MT(ASCP) Monroe Community College Learning Objectives Describe the epidemiology and incidence of bacterial STDs in the U.S. Describe current detection
More informationMarc Steben, President Marie-Claude Drouin, Coordinator STBBIs Committee/Unit
Working from a sexual health or harm reduction perspective: Integration of HIV, HCV and other sexually transmitted and bloodborne infections (STBBIs): Evidence and practice Marc Steben, President Marie-Claude
More informationGonorrhea Antimicrobial Resistance in Alberta. Gonorrhea Antimicrobial Resistance Review
2011 Review in Alberta Alberta Gonorrhea AMR Surveillance Working Group November 2013 2011 Review Background Gonorrhea remains one of the oldest infections known to man. Infections can result in significant
More informationManitoba Health Statistical Update on HIV/AIDS
Manitoba Health Statistical Update on HIV/AIDS 1985 - Dec 2001 Communicable Disease Control Unit Public Health Branch MANITOBA HEALTH STATISTICAL UPDATE ON HIV/AIDS 1985 TO DECEMBER 2001 HIV January 1,
More informationNeisseria gonorrhoeae: The Ontario perspective. Michael Whelan and Dr. Vanessa Allen PHO Grand Rounds, May 5, 2015
Neisseria gonorrhoeae: The Ontario perspective Michael Whelan and Dr. Vanessa Allen PHO Grand Rounds, May 5, 2015 Objectives Participants will be able to: Describe preferred specimen collection for testing
More informationSTOP HIV/AIDS Pilot Project
STOP HIV/AIDS Pilot Project QUARTERLY INDICATORS REPORT: 1 April through 30 June 2011 () SUBMITTED TO: The BC Ministry of Health Services SUBMITTED BY: Dr. Rolando Barrios, Dr. Mark Gilbert, Dr. Kate Health,
More informationAuthorization for vaccination
FOR USE BY CLSC INFORMATION RELATING TO VACCINATION Free Vaccination programs File no FIRST dose in grade 4 elementary school CONTRAINDICATION TO VACCINATION (specify) You must fill out the vaccination
More informationComprehensive Epi Update: HIV, AIDS and STI Mark Gilbert, MD
Comprehensive Epi Update: HIV, AIDS and STI Mark Gilbert, MD February 2014 Objectives Recognize importance of disease syndemics To review current provincial trends: HIV AIDS Infectious syphilis Chlamydia
More informationDescriptive Epidemiology of STBBIs in the Winnipeg Health Region
Descriptive Epidemiology of STBBIs in the Winnipeg Health Region Pierre Plourde Souradet Shaw Debbie Nowicki Mandy Whitlock March 22, 211 Methods Case definitions and case reporting In Manitoba, all confirmed
More informationSexually transmitted infections (in women)
Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:
More information2012 California Clinical Laboratory Survey: STD/HIV/Hepatitis Testing
2012 California Clinical Laboratory Survey: STD/HIV/Hepatitis Testing Joan M. Chow, MPH, DrPH Surveillance, Epidemiology, Assessment & Evaluation Section Sexually Transmitted Disease Control Branch Division
More informationNothing to disclose.
Update on Diagnosis and Treatment Lisa Winston, MD University of California, San Francisco/ Zuckerberg San Francisco General Nothing to disclose. 1 This talk will be a little depressing Rising incidence
More informationNovos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections]
Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections] Khalil Ghanem, MD, PhD Associate Professor of Medicine Directors, STD/HIV/TB
More informationIndex. Infect Dis Clin N Am 19 (2005) Note: Page numbers of article titles are in boldface type.
Infect Dis Clin N Am 19 (2005) 563 568 Index Note: Page numbers of article titles are in boldface type. A Abstinence in genital herpes management, 436 Abuse sexual childhood sexual behavior effects of,
More informationSTOP HIV/AIDS Pilot Project
STOP HIV/AIDS Pilot Project QUARTERLY INDICATORS REPORT: 1 January through 31 March 2012 () SUBMITTED TO: The BC Ministry of Health SUBMITTED BY: Dr. Mark Gilbert and Dr. Kate Heath On behalf of The STOP
More informationGovernment of Canada Federal AIDS Initiative Milestones
HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for
More informationBURNING & SQUIRMING WHAT S NEW IN SEXUALLY TRANSMITTED INFECTIONS
BURNING & SQUIRMING WHAT S NEW IN SEXUALLY TRANSMITTED INFECTIONS Dr. Joss Reimer MD MPH FRCPC Medical Officer of Health, WRHA & Manitoba Health Assistant Professor, Departments of Community Health Sciences
More informationGuidelines for the Laboratory Detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Treponema pallidum Testing
Guidelines for the Laboratory Detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Treponema pallidum Testing Recommendations from the an expert consultation meeting held at CDC January 13-15,
More informationSURVEY OF CONGENITAL RUBELLA SYNDROME, MONTREAL, LAVAL, AND MONTÉRÉGIE, QUEBEC,
Contained in this issue: (No. of pages: 5) Vol. 22 5 SURVEY OF CONGENITAL RUBELLA SYNDROME, MONTREAL, LAVAL, AND MONTÉRÉGIE, QUEBEC, 1985 1991................. F-1 33 35 SURVEILLANCE OF CONGENITAL RUBELLA
More informationSmoking Cessation Counselling
Smoking Cessation Counselling Results of a 2005 Survey of Quebec NURSES Michèle Tremblay, Daniel Cournoyer, Daniela Jukic, Jennifer O Loughlin,, Université de Montréal INTRODUCTION More than 13,000 men
More informationCHLAMYDIA TRACHOMATIS IN CANADA: AN UPDATE
Vol. 23 15 Date of publication: 1 August 1997 Contained in this issue: (No. of pages: 5) Official page numbers: For reference purposes, CHLAMYDIA TRACHOMATIS IN CANADA: AN UPDATE.............. F-1 113-120
More informationGlobal health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )
Regional Committee for Europe 65th session EUR/RC65/Inf.Doc./3 Vilnius, Lithuania, 14 17 September 2015 2 September 2015 150680 Provisional agenda item 3 ORIGINAL: ENGLISH Global health sector strategies
More informationAnnual Statistical Update: HIV and AIDS
Annual Statistical Update: HIV and AIDS 2015 Data reported to December 31, 2015 Epidemiology & Surveillance Public Health Branch Public Health and Primary Health Care Division Manitoba Health, Seniors
More informationAppendix E Genito-Urinary Medicine Codes. Reference Number: DDCN 2013 / 08
Data Dictionary Change Notice NHS Wales Informatics Service Data Standards Subject(s): Approval Status: Appendix E Genito-Urinary Medicine Codes This DDCN was approved by the DSCN Sub-Group on the 5 th
More informationCity and County of Denver Sexually Transmitted Infections Surveillance Report 2005
City and County of Denver Sexually Transmitted Infections Surveillance Report 2005 Denver Public Health Department Sexually Transmitted Disease Control Program November 2006 This report was prepared by:
More informationNational Surveillance of Antimicrobial Susceptibilities of Neisseria gonorrhoeae Annual Summary 2014
1 National Surveillance of Antimicrobial Susceptibilities of Neisseria gonorrhoeae Annual Summary 2012 National Surveillance of Antimicrobial Susceptibilities of Neisseria gonorrhoeae Annual Summary 2014
More informationCDC Grand Rounds: The Growing Threat of Multidrug-
Page 1 of 8 Morbidity and Mortality Weekly Report (MMWR) CDC Grand Rounds: The Growing Threat of Multidrug- Resistant Gonorrhea Weekly February 15, 2013 / 62(06);103-106 Although gonorrhea has afflicted
More informationSTIs- REVISION. Prof A A Hoosen
STIs- REVISION Prof A A Hoosen Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria and the NHLS Microbiology Tertiary Laboratory at the Pretoria Academic Hospital Complex
More informationMonthly Infectious Diseases Surveillance Report
February 2015 Monthly Infectious Diseases Surveillance Report Volume 4, Issue 2 The Monthly Infectious Diseases Surveillance Report is produced by Public Health Ontario (PHO) for the public health community
More informationChapter 11. Sexually Transmitted Diseases
Chapter 11. Sexually Transmitted Diseases General Guidelines Persons identified as having one sexually transmitted disease (STD) are at risk for others and should be screened as appropriate. Partners of
More information5/1/2017. Sexually Transmitted Diseases Burning Questions
Sexually Transmitted Diseases Burning Questions Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Los Angeles, California FORMATTED: 04-03-17 Financial
More informationInfectious syphilis in Canada:
30 CCDR 05 February 2015 Volume 41-2 https://doi.org/10.14745/ccdr.v41i02a03 Infectious syphilis in Canada: 2003-2012 Totten S 1,*, MacLean R 1, Payne E 1 1 Centre for Communicable Diseases and Infection
More informationSTOP HIV/AIDS Pilot Project
STOP HIV/AIDS Pilot Project INDICATORS QUARTERLY REPORT: 1 October through 31 December SUBMITTED TO: The BC Ministry of Health Services SUBMITTED BY: Dr. Rolando Barrios, Dr. Mark Gilbert, Dr. Kate Health,
More informationNew diagnostic tests for sexually transmitted infections. Jens Van Praet 30/11/2018
New diagnostic tests for sexually transmitted infections Jens Van Praet 30/11/2018 Introduction Data from our national microbiological labs suggest STIs are an important clinical issue Correlation with
More informationAntimicrobial Resistant Organisms (ARO) Surveillance SURVEILLANCE REPORT FOR DATA FROM JANUARY TO DECEMBER
Antimicrobial Resistant Organisms (ARO) Surveillance SURVEILLANCE REPORT FOR DATA FROM JANUARY 1 2007 TO DECEMBER 31 2011 TO PROMOTE AND PROTECT THE HEALTH OF CANADIANS THROUGH LEADERSHIP, PARTNERSHIP,
More informationSmoking Cessation Counselling
Smoking Cessation Counselling Results of a 2005 Survey of Quebec PHYSICIANS Michèle Tremblay, Daniel Cournoyer, Jennifer O Loughlin,, Université de Montréal INTRODUCTION More than 13,000 men and women
More informationWorld Health Organization. A Sustainable Health Sector
World Health Organization A Sustainable Health Sector Response to HIV Global Health Sector Strategy for HIV/AIDS 2011-2015 (DRAFT OUTLINE FOR CONSULTATION) Version 2.1 15 July 2010 15 July 2010 1 GLOBAL
More informationSmoking Cessation Counselling
Smoking Cessation Counselling Results of a 2005 Survey of Quebec PHARMACISTS Michèle Tremblay, Daniel Cournoyer, Jennifer O Loughlin,, Université de Montréal INTRODUCTION More than 13,000 men and women
More informationSTDs in HIV Clinical Care: New Guidelines on Treatment and Prevention
STDs in HIV Clinical Care: New Guidelines on Treatment and Prevention Palliative Care Conference Faculty Development Conference August 13, 2015 Steven C. Johnson M.D. Director, University of Colorado HIV/AIDS
More informationGenital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham
Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management William M. Geisler M.D., M.P.H. University of Alabama at Birmingham Chlamydia and Gonorrhea Current Epidemiology Chlamydia Epidemiology
More informationGestion du plomb dans l eau potable l approche québécoise de santé publique
Gestion du plomb dans l eau potable l approche québécoise de santé publique Management of lead in drinking water - the public health approach in Québec 16th Canadian National Conference on Drinking Water
More informationHIV and STI trends in Wales
HIV and STI trends in Wales Notes on data sources and interpretation, June 2018 Author: Communicable Disease Surveillance Centre Date: June 2018 v1 Status: Approved Intended Audience: Health professionals
More informationSexually transmitted infections (in women)
Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:
More informationLearning Objectives. STI Update. Case 1 6/1/2016
Learning Objectives STI Update June 16 th, 2016 Madhu Choudhary, MD. FIDSA Assoc. Prof of Medicine Albany Medical College Review screening recommendations for STI in different patient populations Describe
More informationValidation of the MALDI-TOF for the Identification of Neisseria gonorrhoeae
Proposal Validation of the MALDI-TOF for the Identification of Neisseria gonorrhoeae Laboratory Director Sandip H. Shah, Ph.D. 517-335-8063 517-335-8051 (fax) ShahS@Michigan.gov Acting Director, Division
More informationThe epidemiology of hepatitis C in Canada
The epidemiology of hepatitis C in Canada FACT SHEET Published 2017 This fact sheet provides a snapshot of the hepatitis C epidemic in Canada. It is one of a series of fact sheets providing epidemiological
More informationSTD & HIV ANNUAL REPORT. An Annual Review of HIV and STD s reported in Oakland County, Michigan
STD & HIV ANNUAL REPORT 2016 An Annual Review of HIV and STD s reported in Oakland County, Michigan Similar to numbers reported statewide, Oakland County saw an increase in the number of reported cases
More informationThe Silent Disease Inquiry into Hepatitis C in Australia
Australian Government response to the House of Representatives Standing Committee on Health report: The Silent Disease Inquiry into Hepatitis C in Australia November 2016 LIST OF ABBREVIATIONS AHPPC Australian
More informationEHIVQUAL. For use with ehivqual, an electronic web based program for quality of care data collection and review REVIEW PERIOD:
NEW YORK STATE DEPARTMENT OF HEALTH AIDS INSTITUTE EHIVQUAL QUALITY OF CARE INDICATOR DEFINITIONS* * For use with ehivqual, an electronic web based program for quality of care data collection and review
More informationMahoning County Public Health. Epidemiology Response Annex
Mahoning County Public Health Epidemiology Response Annex Created: May 2006 Updated: February 2015 Mahoning County Public Health Epidemiology Response Annex Table of Contents Epidemiology Response Document
More informationEmergence et impact clinique de la résistance aux antibiotiques chez Chlamydia trachomatis, Neisseria gonorrhoeae, les mycoplasmes
Emergence et impact clinique de la résistance aux antibiotiques chez Chlamydia trachomatis, Neisseria gonorrhoeae, les mycoplasmes Cécile Bébéar French National Center for bacterial STIs Bordeaux University
More informationMaking Recommendations on Vaccines: Marrying Science and Best Judgment, a provincial perspective
Making Recommendations on Vaccines: Marrying Science and Best Judgment, a provincial perspective Gaston De Serres, MD, PhD Institut national de santé publique du Québec Laval University Active member of
More informationAnswers to those burning questions -
Answers to those burning questions - Ann Avery MD Infectious Diseases Physician-MetroHealth Medical Center Assistant Professor- Case Western Reserve University SOM Medical Director -Cleveland Department
More information